The first patient with SCD has been dosed in a clinical trial of HBI-002, an experimental, low-dose liquid formulation of ...

Because sickle cell disease is a multisystemic disorder, it can result in a wide range of symptoms, explains columnist.

A student at Kennesaw State is helping develop a low-cost, light-based device to screen for stroke in children with sickle ...

Acute chest syndrome associated with sickle cell is driven by the abnormal activation of the complement cascade, per a study.

The first patient with SCD has been dosed in a clinical trial of HBI-002, an experimental, low-dose liquid formulation of carbon monoxide.

With the Cell and Gene Therapy (CGT) Access Model, states will be reimbursed if cell and gene therapies don't benefit sickle cell patients.

Columnist Tito Oye struggles to describe the pain involved in a sickle cell crisis. She turns to social media to ask her followers for help.

Read about FTX-6058, a potential oral treatment by Fulcrum Therapeutics now in Phase 1 trial that aims to treat SCD by raising fetal hemoglobin levels.

Most people with SCD seem to meet or exceed current level of physical activity recommendations for the general population, a study shows.

The FDA granted orphan drug status to Kind Pharmaceuticals' investigational oral small molecule AND017 to treat SCD.

Sickle cell disease (SCD) may be cured in some individuals by a stem cell transplant. There also are several approved therapies to help manage the condition and its related complications. Some of the ...

The U.S. Food and Drug Administration approved the start of a first clinical trial of CRISPR_SCD001, the first non-viral and CRISPR/Cas9-based gene editing therapy for sickle cell disease (SCD). Both ...